RECOMMENDATIONS AND REIMBURSEMENT STATUS OF ORPHAN DRUGS IN UE COUNTRIES
Author(s)
Kawalec P
Jagiellonian University Medical Collage Institute of Public Health, Krakow, Poland
OBJECTIVES: The aim of this study was to review and compare decisions of particular European HTA Agencies as well as orphan drugs' reimbursement status in corresponding countries. METHODS:
Conference/Value in Health Info
2015-11, ISPOR Europe 2015, Milan, Italy
Value in Health, Vol. 18, No. 7 (November 2015)
Code
PSY114
Topic
Health Policy & Regulatory, Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes, Pricing Policy & Schemes, Reimbursement & Access Policy
Disease
Rare and Orphan Diseases